| REVIEW ARTICLE |
|
| Year : 2021 | Volume
: 10
| Issue : 6 | Page : 221-226 |
|
|
Manifestations and risk factors of COVID-19 and mucormycosis: A mini-review
Jugal Sutradhar1, Bapi Ray Sarkar2
1 Institute of Pharmacy, Harishchandra PG College, Bawan Beegha, Varanasi 221002, India
2 Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, Darjeeling, West Bengal 734013, India
Correspondence Address:
Jugal Sutradhar
Institute of Pharmacy, Harishchandra PG College, Bawan Beegha, Varanasi 221002
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/2221-6189.330739
|
|
|
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has become a pandemic disease. It also increases the risk of co-infections. Mucormycosis is a severe fungal infectious disease and its causative agent, mucormycetes, belongs to an opportunist fungus Mucoraceae family. Mucormycosis in COVID-19 patients with mucormycosis presents an additional challenge worldwide. Mucormycosis shares certain risk factors and signs and symptoms with COVID-19. In this review, we summarize manifestations and risk factors of mucormycosis and COVID-19. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
